Unknown

Dataset Information

Progesterone receptor modulator for emergency contraception: a randomized controlled trial.


ABSTRACT:

Objective

Compare the efficacy and adverse effects of CDB-2914, a new progesterone receptor modulator, to levonorgestrel for emergency contraception.

Methods

We performed a randomized, double-blinded noninferiority trial, enrolling healthy women seeking emergency contraception within 72 hours of unprotected intercourse. Participants were randomly assigned to receive a single dose of 50 mg of CDB-2914, plus a placebo 12 hours later or two doses of 0.75 mg of levonorgestrel taken 12 hours apart. Follow-up was scheduled 5 to 7 days after the expected onset of the next menstrual period. Posttreatment pregnancy was established by a positive urine test at follow-up and confirmed by quantitative serum beta-hCG. Daily diaries were used from the time of emergency contraception use un

SUBMITTER: Creinin MD 

PROVIDER: S-EPMC2853373 | biostudies-literature | 2006 Nov

REPOSITORIES: biostudies-literature